The acylation of 7-amino-4-methylcoumarin yielded different amides [64] that were screened against five enzymatic targets (AChE, BChE, MAO A and B, BACE) involved in AD pathology at different levels. This evidence concerns the gene BACE1 and Alzheimer disease.